Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carbone

Showing results (501-510 of 651) with videos related to

Pageof 66
Sort By:
Carcinogenesis|December 22, 2006
Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinomaArisa Imsumran, Yasushi Adachi, Hiroyuki Yamamoto, et al.
Journal of Korean Medical Science|June 1, 1993
Comparison of p53 gene mutations in paired primary and metastatic gastric tumor tissuesJ H Kim, J J Choi, S H Noh, et al.
Cancer Medicine|December 15, 2025
Trends in Pleural Mesothelioma Incidence and Survival in Metropolitan and Nonmetropolitan Areas in the United StatesAlexander J Didier, Charlotte Lennox, Mingjia Li, et al.
Cancer Research|August 17, 2006
Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancerHeath B Acuff, Mark Sinnamon, Barbara Fingleton, et al.
Journal for Immunotherapy of Cancer|January 17, 2023
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysisRichard S P Huang, David P Carbone, Gerald Li, et al.
Lung Cancer (Amsterdam, Netherlands)|December 29, 2009
VeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumabDavid P Carbone, J Stuart Salmon, Dean Billheimer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 27, 2021
The International Association for the Study of Lung Cancer Molecular Database Project: Objectives, Challenges, and OpportunitiesRaymond U Osarogiagbon, Ramon Rami-Porta, Ming Sound Tsao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphomaM J O'Connell, D P Harrington, J D Earle, et al.
Molecular & Cellular Proteomics : MCP|March 2, 2011
Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometryHaixia Zhang, Qinfeng Liu, Lisa J Zimmerman, et al.
Cancer Gene Therapy|December 19, 2002
Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancerChoon-Taek Lee, Kyung-Ho Park, Yasushi Adachi, et al.
Pageof 66

Showing results (501-510 of 651) with videos related to

Sort By:
Pageof 66
Carcinogenesis|December 22, 2006
Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinomaArisa Imsumran, Yasushi Adachi, Hiroyuki Yamamoto, et al.
Journal of Korean Medical Science|June 1, 1993
Comparison of p53 gene mutations in paired primary and metastatic gastric tumor tissuesJ H Kim, J J Choi, S H Noh, et al.
Cancer Medicine|December 15, 2025
Trends in Pleural Mesothelioma Incidence and Survival in Metropolitan and Nonmetropolitan Areas in the United StatesAlexander J Didier, Charlotte Lennox, Mingjia Li, et al.
Cancer Research|August 17, 2006
Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancerHeath B Acuff, Mark Sinnamon, Barbara Fingleton, et al.
Journal for Immunotherapy of Cancer|January 17, 2023
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysisRichard S P Huang, David P Carbone, Gerald Li, et al.
Lung Cancer (Amsterdam, Netherlands)|December 29, 2009
VeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumabDavid P Carbone, J Stuart Salmon, Dean Billheimer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 27, 2021
The International Association for the Study of Lung Cancer Molecular Database Project: Objectives, Challenges, and OpportunitiesRaymond U Osarogiagbon, Ramon Rami-Porta, Ming Sound Tsao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphomaM J O'Connell, D P Harrington, J D Earle, et al.
Molecular & Cellular Proteomics : MCP|March 2, 2011
Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometryHaixia Zhang, Qinfeng Liu, Lisa J Zimmerman, et al.
Cancer Gene Therapy|December 19, 2002
Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancerChoon-Taek Lee, Kyung-Ho Park, Yasushi Adachi, et al.
Pageof 66